Literature DB >> 7534856

Tacrine.

K L Davis1, P Powchik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7534856     DOI： 10.1016/s0140-6736(95)90526-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5H-indolo[2,3-b]quinolin-11-amine: a highly potent human cholinesterase inhibitor.

Authors:  Li Wang; Ignacio Moraleda; Isabel Iriepa; Alejandro Romero; Francisco López-Muñoz; Mourad Chioua; Tsutomu Inokuchi; Manuela Bartolini; José Marco-Contelles
Journal:  Medchemcomm       Date:  2017-04-28       Impact factor: 3.597

2.  Dementia--an update.

Authors:  W Jagust
Journal:  West J Med       Date:  1995-11

3.  Three-dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors.

Authors:  M Harel; G Kryger; T L Rosenberry; W D Mallender; T Lewis; R J Fletcher; J M Guss; I Silman; J L Sussman
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

4.  Investigation of the binding mode of (-)-meptazinol and bis-meptazinol derivatives on acetylcholinesterase using a molecular docking method.

Authors:  Qiong Xie; Yun Tang; Wei Li; Xing-Hai Wang; Zhui-Bai Qiu
Journal:  J Mol Model       Date:  2006-01-11       Impact factor: 1.810

5.  Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: effect against amyloid-β-induced neurotoxicity.

Authors:  Daniel Silva; Mourad Chioua; Abdelouahid Samadi; Paula Agostinho; Pedro Garção; Rocío Lajarín-Cuesta; Cristobal de Los Ríos; Isabel Iriepa; Ignacio Moraleda; Laura Gonzalez-Lafuente; Eduarda Mendes; Concepción Pérez; María Isabel Rodríguez-Franco; José Marco-Contelles; M Carmo Carreiras
Journal:  ACS Chem Neurosci       Date:  2013-02-04       Impact factor: 4.418

6.  Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.

Authors:  Gary Small; Timo Erkinjuntti; Alexander Kurz; Sean Lilienfeld
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Identification of selective inhibitors of acetylcholinesterase from a combinatorial library of 2,5-piperazinediones.

Authors:  T Carbonell; I Masip; F Sánchez-Baeza; M Delgado; E Araya; O Llorens; F Corcho; J J Pérez; E Pérez-Payá; A Messeguer
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

8.  2,3-dihydro-1H-cyclopenta[b]quinoline derivatives as acetylcholinesterase inhibitors-synthesis, radiolabeling and biodistribution.

Authors:  Paweł Szymański; Alice Lázničková; Milan Lázniček; Marek Bajda; Barbara Malawska; Magdalena Markowicz; Elżbieta Mikiciuk-Olasik
Journal:  Int J Mol Sci       Date:  2012-08-13       Impact factor: 6.208

9.  Cyclic peptidomimetic lead compounds to reduce neurotoxicity and associated oxidative stress in Alzheimer's disease.

Authors:  Antara Banerjee; Arpita Yadav
Journal:  Int J Biomed Sci       Date:  2010-09

10.  Metabolite profiling and biological activities of bioactive compounds produced by Chrysosporium lobatum strain BK-3 isolated from Kaziranga National Park, Assam, India.

Authors:  C Ganesh Kumar; Poornima Mongolla; Pombala Sujitha; Joveeta Joseph; K Suresh Babu; Gangi Suresh; Kallaganti Venkata Siva Ramakrishna; Uppula Purushotham; G Narahari Sastry; Ahmed Kamal
Journal:  Springerplus       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.